| Current Price | $51.04 | Mkt Cap | $4.9B |
|---|---|---|---|
| Open | $50.58 | P/E Ratio | 0.00 |
| Prev. Close | $50.35 | Div. (Yield) | $1.84 (0.0%) |
| Daily Range | $50.29 - $51.26 | Volume | 130,371 |
| 52-Wk Range | $38.01 - $51.26 | Avg. Daily Vol. | 12 |
| Current Price | $51.04 | Mkt Cap | $4.9B |
|---|---|---|---|
| Open | $50.58 | P/E Ratio | 0.00 |
| Prev. Close | $50.35 | Div. (Yield) | $1.84 (0.0%) |
| Daily Range | $50.29 - $51.26 | Volume | 130,371 |
| 52-Wk Range | $38.01 - $51.26 | Avg. Daily Vol. | 12 |
The best Bull and Bear pitches based on recency and number of recommendations.
Founder-led, cash rich, steady cash flows that it invests in reasonable acquisitions. The new Excelsius spinal solutions still awaiting FDA approval but expects to be more significant contributor over the next several years.
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about GMED.
Recs
401ktimer1
(98.56)
Submitted: 10/2/2018 11:53:42 AM :
Start Price:
$54.81
NYSE:GMED Score:
-6.94
IBD 50 Oct 1, 2018
Recs
TMFTypeoh
(92.83)
Submitted: 4/17/2018 12:25:57 PM :
Start Price:
$50.34
NYSE:GMED Score:
-6.83
Looks like a winner
Recs
TMFOpie
(91.86)
Submitted: 5/26/2017 10:49:35 AM :
Start Price:
$31.11
NYSE:GMED Score:
+43.08
Founder-led, cash rich, steady cash flows that it invests in reasonable acquisitions. The new Excelsius spinal solutions still awaiting FDA approval but expects to be more significant contributor over the next several years.
Find the members with the highest scoring picks in GMED.
pungocatfish (< 20) Score: +266.25
The Score Leader is the player with the highest score across all their picks in GMED.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| pungocatfish | < 20 | 1/3/2013 |
|
3Y | $10.94 | +366.54% | +100.29% | +266.25 | 0 Comment | |
| Squeege1981 | < 20 | 12/24/2012 |
|
3Y | $10.96 | +365.69% | +105.23% | +260.46 | 0 Comment | |
| PerdidoBeacher | 55.77 | 12/20/2012 |
|
5Y | $11.34 | +350.09% | +102.53% | +247.56 | 0 Comment | |
| Biotechnut | < 20 | 12/3/2012 |
|
5Y | $12.05 | +323.57% | +106.31% | +217.25 | 0 Comment | |
| jayimsu | 52.73 | 4/30/2013 |
|
5Y | $14.79 | +245.10% | +83.59% | +161.50 | 0 Comment | |
| Mostad08 | 61.95 | 5/22/2013 |
|
5Y | $15.76 | +223.86% | +74.72% | +149.14 | 0 Comment | |
| Santa007 | < 20 | 8/15/2012 |
|
3Y | $14.32 | +256.40% | +107.56% | +148.84 | 2 Comments | |
| NewClueLess | 42.44 | 11/11/2013 |
|
5Y | $18.52 | +175.59% | +65.09% | +110.50 | 0 Comment | |
| jsnms | 24.60 | 12/17/2013 |
|
5Y | $19.10 | +167.23% | +63.03% | +104.20 | 0 Comment | |
| sandvig | 98.61 | 11/10/2016 |
|
5Y | $21.61 | +136.19% | +34.57% | +101.62 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
| Player Name | Player Rating |
Start Date |
Call | Time Frame |
Start Price |
Stock Gain |
S&P Gain |
Score | End Date | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| TrackCanaccord | 66.78 | 1/22/2014 |
|
NS | $23.09 | +121.05% | +58.50% | +62.55 | 0 Comment | |
| TrackWallachBeth | 44.74 | 5/17/2013 |
|
NS | $15.52 | +228.87% | +76.20% | +152.66 | 0 Comment | |
| TrackJimCramer | 86.50 | 12/17/2012 |
|
3W | $11.61 | +339.62% | +103.39% | -236.23 | 0 Comment | |
| TrackPiperJaff | 84.83 | 8/28/2012 |
|
NS | $15.45 | +230.36% | +107.12% | +123.24 | 0 Comment |
